BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G, Ringe B. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996;224:628-38. [PMID: 8916878 DOI: 10.1097/00000658-199611000-00007] [Cited by in Crossref: 219] [Cited by in F6Publishing: 186] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Ersan V, Usta S, Aydin C, Carr BI, Karatoprak S, Yilmaz S. Critical overview of resection for Bismuth-Corlette type IV perihilar cholangiocarcinoma. Acta Chir Belg 2022;:1-8. [PMID: 35549649 DOI: 10.1080/00015458.2022.2078030] [Reference Citation Analysis]
2 Qiu Y, Huang B, Yang X, Wang T, Shen S, Yang Y, Wang W. Evaluating the Benefits and Risks of Ex Vivo Liver Resection and Autotransplantation in Treating Hepatic End-stage Alveolar Echinococcosis. Clin Infect Dis 2022:ciac195. [PMID: 35271705 DOI: 10.1093/cid/ciac195] [Reference Citation Analysis]
3 Qiu Y, Yang X, Wang T, Shen S, Yang Y, Huang B, Wang W. Learning Curve of Ex Vivo Liver Resection and Autotransplantation in Treating End-Stage Hepatic Alveolar Echinococcosis: A RA-CUSUM Analysis. Front Surg 2021;8:753968. [PMID: 34917647 DOI: 10.3389/fsurg.2021.753968] [Reference Citation Analysis]
4 Yilmaz S, Carr BI, Akbulut S. Can the Limits of Liver Transplantation Be Expanded in Perihilar Cholangiocarcinoma? J Gastrointest Cancer 2021. [PMID: 34738188 DOI: 10.1007/s12029-021-00735-6] [Reference Citation Analysis]
5 Rodriguez RR, Abel S, Mamadgi J, Renz PB, Wegner RE, Raj MS. Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review. J Gastrointest Cancer 2021. [PMID: 34486086 DOI: 10.1007/s12029-021-00696-w] [Reference Citation Analysis]
6 Panayotova G, Guerra J, Guarrera JV, Lunsford KE. The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma. J Clin Med 2021;10:2428. [PMID: 34070772 DOI: 10.3390/jcm10112428] [Reference Citation Analysis]
7 Panayotova G, Lunsford KE, Latt NL, Paterno F, Guarrera JV, Pyrsopoulos N. Expanding indications for liver transplantation in the era of liver transplant oncology. World J Gastrointest Surg 2021; 13(5): 392-405 [PMID: 34122730 DOI: 10.4240/wjgs.v13.i5.392] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
8 Tang W, Qiu JG, Deng X, Liu SS, Cheng L, Liu JR, Du CY. Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness. PLoS One 2021;16:e0248534. [PMID: 33705481 DOI: 10.1371/journal.pone.0248534] [Reference Citation Analysis]
9 Lee SH, Choi GH, Han DH, Kim KS, Choi JS, Rho SY. Chronological analysis of surgical and oncological outcomes after the treatment of perihilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2021;25:62-70. [PMID: 33649256 DOI: 10.14701/ahbps.2021.25.1.62] [Reference Citation Analysis]
10 Moreau J, Lapeyre M, Benoit C, Pezet D, Biau J. [Intra and extra hepatic cholangiocarcinomas radiation therapy]. Cancer Radiother 2021;25:175-81. [PMID: 33423966 DOI: 10.1016/j.canrad.2020.06.039] [Reference Citation Analysis]
11 Yohanathan L, Croome KP, Traynor M, Puig CA, Mara KC, Cleary SP, Nagorney DM. Significance of proximal ductal margin status after resection of hilar cholangiocarcinoma. HPB (Oxford) 2021;23:109-17. [PMID: 32593583 DOI: 10.1016/j.hpb.2020.05.002] [Reference Citation Analysis]
12 Hirsch TZ, Negulescu A, Gupta B, Caruso S, Noblet B, Couchy G, Bayard Q, Meunier L, Morcrette G, Scoazec JY, Blanc JF, Amaddeo G, Nault JC, Bioulac-Sage P, Ziol M, Beaufrère A, Paradis V, Calderaro J, Imbeaud S, Zucman-Rossi J. BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA. J Hepatol 2020;72:924-36. [PMID: 31862487 DOI: 10.1016/j.jhep.2019.12.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
13 Nagino M. Fifty-year history of biliary surgery. Ann Gastroenterol Surg. 2019;3:598-605. [PMID: 31788648 DOI: 10.1002/ags3.12289] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
14 Amer A, Wilson CH, Manas DM. Liver transplantation for unresectable malignancies: Beyond hepatocellular carcinoma. Eur J Surg Oncol 2019;45:2268-78. [PMID: 31387755 DOI: 10.1016/j.ejso.2019.07.024] [Reference Citation Analysis]
15 Moris D, Kostakis ID, Machairas N, Prodromidou A, Tsilimigras DI, Ravindra KV, Sudan DL, Knechtle SJ, Barbas AS. Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis. PLoS One. 2019;14:e0220527. [PMID: 31365594 DOI: 10.1371/journal.pone.0220527] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
16 Lee Y, Choi D, Han S, Han IW, Heo JS, Choi SH. Comparison analysis of left-side versus right-side resection in bismuth type III hilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2018;22:350-8. [PMID: 30588526 DOI: 10.14701/ahbps.2018.22.4.350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
17 Zhao HP, Zhang ZH, Zheng AH. Assessment of treatment outcomes in patients with advanced hilar cholangiocarcinoma (stages III-IV): Clinical significance of interventional therapy. Medicine (Baltimore). 2018;97:e11550. [PMID: 30278479 DOI: 10.1097/md.0000000000011550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
18 Mittler J, Heinrich S, Lang H. [Indications for transplantation and bridging procedures for primary hepatobiliary malignancies]. Chirurg 2018;89:865-71. [PMID: 30238348 DOI: 10.1007/s00104-018-0733-z] [Reference Citation Analysis]
19 Wakai T, Sakata J, Katada T, Hirose Y, Soma D, Prasoon P, Miura K, Kobayashi T. Surgical management of carcinoma in situ at ductal resection margins in patients with extrahepatic cholangiocarcinoma. Ann Gastroenterol Surg 2018;2:359-66. [PMID: 30238077 DOI: 10.1002/ags3.12196] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
20 Lin YK, Hsieh MC, Wang WW, Lin YC, Chang WW, Chang CL, Cheng YF, Wu SY. Outcomes of adjuvant treatments for resectable intrahepatic cholangiocarcinoma: Chemotherapy alone, sequential chemoradiotherapy, or concurrent chemoradiotherapy. Radiother Oncol 2018;128:575-83. [PMID: 29801723 DOI: 10.1016/j.radonc.2018.05.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
21 Bhutiani N, Scoggins CR, Mcmasters KM, Ethun CG, Poultsides GA, Pawlik TM, Weber SM, Schmidt CR, Fields RC, Idrees K, Hatzaras I, Shen P, Maithel SK, Martin RC. The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium. Surgery 2018;163:726-31. [DOI: 10.1016/j.surg.2017.10.028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
22 Tang R, Ma L, Xiang C, Wang X, Li A, Liao H, Dong J. Augmented reality navigation in open surgery for hilar cholangiocarcinoma resection with hemihepatectomy using video-based in situ three-dimensional anatomical modeling: A case report. Medicine (Baltimore) 2017;96:e8083. [PMID: 28906410 DOI: 10.1097/MD.0000000000008083] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
23 Rosen CB, Heimbach JK, Gores GJ. Current status of liver transplantation for hilar cholangiocarcinoma. Curr Opin Organ Transplant 2007;12:215-9. [PMID: 27711007 DOI: 10.1097/MOT.0b013e32814e6b7d] [Reference Citation Analysis]
24 Kim YJ, Kim K, Min SK, Nam EM. Role of adjuvant radiotherapy for localized extrahepatic bile duct cancer. Br J Radiol. 2017;90:20160807. [PMID: 28118028 DOI: 10.1259/bjr.20160807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
25 Vaquero J, Guedj N, Clapéron A, Nguyen Ho-bouldoires TH, Paradis V, Fouassier L. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks. Journal of Hepatology 2017;66:424-41. [DOI: 10.1016/j.jhep.2016.09.010] [Cited by in Crossref: 55] [Cited by in F6Publishing: 63] [Article Influence: 11.0] [Reference Citation Analysis]
26 Lehrke HD, Heimbach JK, Wu TT, Jenkins SM, Gores GJ, Rosen CB, Mounajjed T. Prognostic Significance of the Histologic Response of Perihilar Cholangiocarcinoma to Preoperative Neoadjuvant Chemoradiation in Liver Explants. Am J Surg Pathol. 2016;40:510-518. [PMID: 26752544 DOI: 10.1097/pas.0000000000000588] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 4.2] [Reference Citation Analysis]
27 Watanabe A, Araki K, Hirai K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Hoshino K, Kuwano H, Shirabe K. A Novel Clinical Factor, D-Dimer Platelet Multiplication, May Predict Postoperative Recurrence and Prognosis for Patients with Cholangiocarcinoma. Ann Surg Oncol 2016;23:886-91. [DOI: 10.1245/s10434-016-5422-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
28 Abd ElWahab M, El Nakeeb A, El Hanafy E, Sultan AM, Elghawalby A, Askr W, Ali M, Abd El Gawad M, Salah T. Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg 2016; 8(6): 436-443 [PMID: 27358676 DOI: 10.4240/wjgs.v8.i6.436] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
29 Peng C, Li C, Wen T, Yan L, Li B. Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: A retrospective cohort study. Int J Surg 2016;32:167-73. [PMID: 27344254 DOI: 10.1016/j.ijsu.2016.06.038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
30 Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122:1349-1369. [PMID: 26799932 DOI: 10.1002/cncr.29692] [Cited by in Crossref: 97] [Cited by in F6Publishing: 128] [Article Influence: 16.2] [Reference Citation Analysis]
31 Gulamhusein AF, Sanchez W. Liver transplantation in the management of perihilar cholangiocarcinoma. Hepat Oncol 2015;2:409-21. [PMID: 30191020 DOI: 10.2217/hep.15.30] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
32 Lederer A, Herrmann P, Seehofer D, Dietel M, Pratschke J, Schlag P, Stein U. Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in Klatskin tumor patients. Hepatology 2015;62:841-50. [PMID: 25953673 DOI: 10.1002/hep.27885] [Cited by in Crossref: 17] [Cited by in F6Publishing: 63] [Article Influence: 2.4] [Reference Citation Analysis]
33 Bertani H, Frazzoni M, Mangiafico S, Caruso A, Manno M, Mirante VG, Pigò F, Barbera C, Manta R, Conigliaro R. Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy. World J Gastrointest Endosc 2015; 7(6): 582-592 [PMID: 26078827 DOI: 10.4253/wjge.v7.i6.582] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
34 Facciuto ME, Singh MK, Lubezky N, Selim MA, Robinson D, Kim-Schluger L, Florman S, Ward SC, Thung SN, Fiel M, Schiano TD. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation. Transplantation. 2015;99:151-157. [PMID: 25029385 DOI: 10.1097/tp.0000000000000286] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
35 Tan Y, Qiu BA, Xia NX, Yang YX, Zhu JY, Liu P, An Y, Wu YT. Liver transplantation for hilar cholangiocarcinoma: Analysis of 7 cases. Shijie Huaren Xiaohua Zazhi 2015; 23(2): 313-317 [DOI: 10.11569/wcjd.v23.i2.313] [Reference Citation Analysis]
36 Kambakamba P, Deoliveira ML. Perihilar cholangiocarcinoma: paradigms of surgical management. The American Journal of Surgery 2014;208:563-70. [DOI: 10.1016/j.amjsurg.2014.05.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
37 Zhang W, Yan LN. Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol 2014; 5(3): 344-354 [PMID: 25133034 DOI: 10.4291/wjgp.v5.i3.344] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
38 Strongin A, Singh H, Eloubeidi MA, Siddiqui AA. Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinoma. Endosc Ultrasound 2013;2:71-6. [PMID: 24949368 DOI: 10.4103/2303-9027.117690] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
39 Strongin A, Singh H, Eloubeidi MA, Siddiqui AA. Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinoma. Endosc Ultrasound. 2013;2:71-76. [PMID: 24949368 DOI: 10.7178/eus.05.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Caillol F, Bories E, Poizat F, Pesenti C, Esterni B, Monges G, Giovannini M. Endomicroscopy in bile duct: Inflammation interferes with pCLE applied in the bile duct: A prospective study of 54 patients. United European Gastroenterol J. 2013;1:120-127. [PMID: 24917949 DOI: 10.1177/2050640613483462] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
41 Watanabe A, Suzuki H, Yokobori T, Tsukagoshi M, Altan B, Kubo N, Suzuki S, Araki K, Wada S, Kashiwabara K. Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma. Cancer Sci. 2014;105:690-696. [PMID: 24708177 DOI: 10.1111/cas.12417] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
42 Ravaioli M, Ercolani G, Neri F, Cescon M, Stacchini G, Gaudio MD, Cucchetti A, Pinna AD. Liver transplantation for hepatic tumors: A systematic review. World J Gastroenterol 2014; 20(18): 5345-5352 [PMID: 24833864 DOI: 10.3748/wjg.v20.i18.5345] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
43 Chang YR, Lee KB, Jang J, Lim C, Kang MJ, Kwon W, Jung WH, Kim S. Analysis of Microscopic Tumor Spread Patterns According to Gross Morphologies and Suggestions for Optimal Resection Margins in Bile Duct Cancer. J Gastrointest Surg 2014;18:1146-54. [DOI: 10.1007/s11605-014-2518-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
44 Iso Y, Kita J, Kato M, Shimoda M, Kubota K. When hepatic-side ductal margin is positive in N+ cases, additional resection of the bile duct is not necessary to render the negative hepatic-side ductal margin during surgery for extrahepatic distal bile duct carcinoma. Med Sci Monit 2014;20:471-5. [PMID: 24657986 DOI: 10.12659/MSM.889714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
45 Lee SJ, Kwon W, Kang MJ, Jang JY, Chang YR, Jung W, Kim SW. Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma. Korean J Hepatobiliary Pancreat Surg 2014;18:1-8. [PMID: 26155239 DOI: 10.14701/kjhbps.2014.18.1.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Pan H, Liang Z, Yin TS, Xie Y, Li DW. Hepato-biliary-enteric stent drainage as palliative treatment for proximal malignant obstructive jaundice. Med Oncol 2014;31:853. [PMID: 24464214 DOI: 10.1007/s12032-014-0853-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
47 Singal A, Welling TH, Marrero JA. Role of liver transplantation in the treatment of cholangiocarcinoma. Expert Review of Anticancer Therapy 2014;9:491-502. [DOI: 10.1586/era.09.5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
48 Brass V, Kuhlmann JB, Blum HE. Current state of nonsurgical therapies for cholangiocarcinoma. Hepat Oncol 2014;1:135-42. [PMID: 30190947 DOI: 10.2217/hep.13.9] [Reference Citation Analysis]
49 Furusawa N, Kobayashi A, Yokoyama T, Shimizu A, Motoyama H, Miyagawa S. Surgical Treatment of 144 Cases of Hilar Cholangiocarcinoma Without Liver-Related Mortality. World J Surg 2014;38:1164-76. [DOI: 10.1007/s00268-013-2394-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
50 Watanabe A, Suzuki H, Yokobori T, Altan B, Kubo N, Araki K, Wada S, Mochida Y, Sasaki S, Kashiwabara K. Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis. Cancer Sci. 2013;104:1427-1432. [PMID: 23919841 DOI: 10.1111/cas.12249] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
51 Serrablo A, Tejedor L. Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol 2013; 5(7): 147-158 [PMID: 23919109 DOI: 10.4251/wjgo.v5.i7.147] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
52 Lee CW, Kuo WL, Yu MC, Chen TC, Tsai CN, Lee WC, Chen MF. The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection. World J Surg Oncol. 2013;11:136. [PMID: 23758804 DOI: 10.1186/1477-7819-11-136] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
53 Tsurusaki M, Okada M, Kuroda H, Matsuki M, Ishii K, Murakami T. Clinical application of 18F-fluorodeoxyglucose positron emission tomography for assessment and evaluation after therapy for malignant hepatic tumor. J Gastroenterol 2014;49:46-56. [PMID: 23525980 DOI: 10.1007/s00535-013-0790-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
54 Esaki M, Shimada K, Nara S, Kishi Y, Sakamoto Y, Kosuge T, Sano T. Left hepatic trisectionectomy for advanced perihilar cholangiocarcinoma. Br J Surg. 2013;100:801-807. [PMID: 23460314 DOI: 10.1002/bjs.9099] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
55 Wadsworth CA, Lim A, Taylor-robinson SD, Khan SA. The risk factors and diagnosis of cholangiocarcinoma. Hepatol Int 2013;7:377-93. [DOI: 10.1007/s12072-012-9407-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
56 Quyn AJ, Ziyaie D, Polignano FM, Tait IS. Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford). 2009;11:570-577. [PMID: 20495709 DOI: 10.1111/j.1477-2574.2009.00102.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
57 Levy MJ, Heimbach JK, Gores GJ. Endoscopic ultrasound staging of cholangiocarcinoma. Curr Opin Gastroenterol. 2012;28:244-252. [PMID: 22274618 DOI: 10.1097/mog.0b013e32835005bc] [Cited by in Crossref: 44] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
58 Rosen CB, Darwish Murad S, Heimbach JK, Nyberg SL, Nagorney DM, Gores GJ. Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary? J Am Coll Surg. 2012;215:31-38; discussion 38-40. [PMID: 22621893 DOI: 10.1016/j.jamcollsurg.2012.03.014] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
59 LaFemina J, Jarnagin WR. Surgical management of proximal bile duct cancers. Langenbecks Arch Surg. 2012;397:869-879. [PMID: 22391776 DOI: 10.1007/s00423-012-0928-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
60 Gu J, Bai J, Shi X, Zhou J, Qiu Y, Wu Y, Jiang C, Sun X, Xu F, Zhang Y. Efficacy and safety of liver transplantation in patients with cholangiocarcinoma: a systematic review and meta-analysis. Int J Cancer. 2012;130:2155-2163. [PMID: 21387295 DOI: 10.1002/ijc.26019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
61 Lee CW, Chan KM, Lee CF, Yu MC, Lee WC, Wu TJ, Chen MF. Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome. Asian J Surg 2011;34:53-62. [PMID: 21723467 DOI: 10.1016/S1015-9584(11)60020-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
62 Ribero D, Amisano M, Lo Tesoriere R, Rosso S, Ferrero A, Capussotti L. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma. Ann Surg. 2011;254:776-81; discussion 781-3. [PMID: 22042470 DOI: 10.1097/sla.0b013e3182368f85] [Cited by in Crossref: 63] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
63 Kim JH. Endoscopic stent placement in the palliation of malignant biliary obstruction. Clin Endosc 2011;44:76-86. [PMID: 22741117 DOI: 10.5946/ce.2011.44.2.76] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
64 Schwartz JJ, Thiesset HF, Clayton F, Adler DG, Hutson WR, Carlisle JG. Using the modern Silverhawk™ atherectomy catheter to characterize biliary structures that appear malignant: review of initial experience. HPB (Oxford) 2011;13:823-9. [PMID: 21999597 DOI: 10.1111/j.1477-2574.2011.00376.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-vallée J, Duvoux C, Lerut J, Le Treut Y, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F. Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score-based liver allocation system: Meld Exceptions in the French System. Liver Transpl 2011;17:1137-51. [DOI: 10.1002/lt.22363] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
66 Skipworth JR, Olde Damink SW, Imber C, Bridgewater J, Pereira SP, Malagó M. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther. 2011;34:1063-1078. [PMID: 21933219 DOI: 10.1111/j.1365-2036.2011.04851.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 5.7] [Reference Citation Analysis]
67 Zografos GN, Farfaras A, Zagouri F, Chrysikos D, Karaliotas K. Cholangiocarcinoma: principles and current trends. Hepatobiliary Pancreat Dis Int 2011;10:10-20. [PMID: 21269929 DOI: 10.1016/s1499-3872(11)60001-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
68 Carbone M, Neuberger J. Liver transplantation in PBC and PSC: Indications and disease recurrence. Clinics and Research in Hepatology and Gastroenterology 2011;35:446-54. [DOI: 10.1016/j.clinre.2011.02.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
69 Li H, Qin Y, Cui Y, Chen H, Hao X, Li Q. Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience. Dig Surg. 2011;28:226-231. [PMID: 21540611 DOI: 10.1159/000327361] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
70 Heimbach JK, Sanchez W, Rosen CB, Gores GJ. Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford). 2011;13:356-360. [PMID: 21492336 DOI: 10.1111/j.1477-2574.2011.00298.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 155] [Article Influence: 12.7] [Reference Citation Analysis]
71 Matull WR, Dhar DK, Ayaru L, Sandanayake NS, Chapman MH, Dias A, Bridgewater J, Webster GJ, Bong JJ, Davidson BR, Pereira SP. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int 2011;31:99-107. [PMID: 20846273 DOI: 10.1111/j.1478-3231.2010.02345.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
72 Yasuda Y, Larsen PN, Ishibashi T, Yamashita K, Toei H. Resection of hilar cholangiocarcinoma with left hepatectomy after pre-operative embolization of the proper hepatic artery. HPB (Oxford) 2010;12:147-52. [PMID: 20495660 DOI: 10.1111/j.1477-2574.2009.00152.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
73 Alvaro D, Cannizzaro R, Labianca R, Valvo F, Farinati F, Italian Society of Gastroenterology (SIGE), Italian Association of Hospital Gastroenterology (AIGO), Italian Association of Medical Oncology (AIOM), Italian Association of Oncological Radiotherapy (AIRO). Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). Dig Liver Dis. 2010;42:831-838. [PMID: 20702152 DOI: 10.1016/j.dld.2010.06.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
74 Lang H, Sotiropoulos GC, Kaiser GM, Molmenti EP, Malagó M, Broelsch CE. The role of liver transplantation in the treatment of hilar cholangiocarcinoma. HPB (Oxford) 2005;7:268-72. [PMID: 18333205 DOI: 10.1080/13651820500372780] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
75 Kloek JJ, Ten Kate FJ, Busch OR, Gouma DJ, van Gulik TM. Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) 2008;10:190-5. [PMID: 18773053 DOI: 10.1080/13651820801992575] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
76 Capussotti L, Vigano L, Ferrero A, Muratore A. Local surgical resection of hilar cholangiocarcinoma: is there still a place? HPB (Oxford). 2008;10:174-178. [PMID: 18773049 DOI: 10.1080/13651820801992534] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
77 Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int. 2010;23:692-697. [PMID: 20497401 DOI: 10.1111/j.1432-2277.2010.01108.x] [Cited by in Crossref: 162] [Cited by in F6Publishing: 173] [Article Influence: 13.5] [Reference Citation Analysis]
78 Witzigmann H, Lang H, Lauer H. Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford). 2008;10:154-160. [PMID: 18773044 DOI: 10.1080/13651820801992567] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
79 Meza-Junco J, Montano-Loza AJ, Ma M, Wong W, Sawyer MB, Bain VG. Cholangiocarcinoma: has there been any progress? Can J Gastroenterol 2010;24:52-7. [PMID: 20186357 DOI: 10.1155/2010/704759] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
80 Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Capelli P, Pedica F, Nicoli P, Conci S, Iacono C. Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? J Surg Oncol 2010;101:111-5. [PMID: 19953578 DOI: 10.1002/jso.21452] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
81 Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Miyazaki M. Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann Surg. 2010;251:281-286. [PMID: 20054275 DOI: 10.1097/sla.0b013e3181be0085] [Cited by in Crossref: 74] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
82 Seehofer D, Thelen A, Neumann UP, Veltzke-Schlieker W, Denecke T, Kamphues C, Pratschke J, Jonas S, Neuhaus P. Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results. Liver Transpl. 2009;15:1499-1507. [PMID: 19877250 DOI: 10.1002/lt.21887] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
83 Kobayashi A, Miwa S, Nakata T, Miyagawa S. Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg. 2010;97:56-64. [PMID: 19937985 DOI: 10.1002/bjs.6788] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 5.2] [Reference Citation Analysis]
84 Lee HG, Lee SH, Yoo DD, Paik KY, Heo JS, Choi SH, Choi DW. Carcinoma of the middle bile duct: Is bile duct segmental resection appropriate? World J Gastroenterol 2009; 15(47): 5966-5971 [PMID: 20014461 DOI: 10.3748/wjg.15.5966] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
85 Nguyen KT, Steel J, Vanounou T, Tsung A, Marsh JW, Geller DA, Gamblin TC. Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? Ann Surg Oncol 2009;16:3308-15. [PMID: 19774418 DOI: 10.1245/s10434-009-0701-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
86 Kornberg A, Küpper B, Thrum K, Wilberg J, Sappler A, Gottschild D. Recurrence-free long-term survival after liver transplantation in patients with 18F-FDG non-avid hilar cholangiocarcinoma on PET. Am J Transplant. 2009;9:2631-2636. [PMID: 19775312 DOI: 10.1111/j.1600-6143.2009.02821.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
87 Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15(34): 4240-4262 [PMID: 19750567 DOI: 10.3748/wjg.15.4240] [Cited by in CrossRef: 180] [Cited by in F6Publishing: 165] [Article Influence: 13.8] [Reference Citation Analysis]
88 Heimbach J. Hilar Cholangiocarcinoma and Liver Transplantation. Transplantation 2009;88:299-300. [DOI: 10.1097/tp.0b013e3181adca5a] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
89 Schwartz JJ, Hutson WR, Gayowski TJ, Sorensen JB. Liver Transplantation for Cholangiocarcinoma. Transplantation 2009;88:295-8. [DOI: 10.1097/tp.0b013e3181adc9e5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
90 Shimizu H, Sawada S, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Miyazaki M. Clinical significance of biliary vascular anatomy of the right liver for hilar cholangiocarcinoma applied to left hemihepatectomy. Ann Surg. 2009;249:435-439. [PMID: 19247031 DOI: 10.1097/sla.0b013e31819a6c10] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
91 Seyama Y, Kokudo N, Makuuchi M. Radical Resection of Biliary Tract Cancers and the Role of Extended Lymphadenectomy. Surgical Oncology Clinics of North America 2009;18:339-59. [DOI: 10.1016/j.soc.2008.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Akoad M, Jenkins R. Proximal biliary malignancy. Surg Clin North Am. 2008;88:1409-1428, x-xi. [PMID: 18992602 DOI: 10.1016/j.suc.2008.07.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
93 Machimoto T, Doi R, Ogawa K, Masui T, Seo S, Uemoto S. Abdominal wall recurrence of Hilar bile duct cancer 12 years after a curative resection: report of a case. Surg Today 2009;39:72-6. [PMID: 19132474 DOI: 10.1007/s00595-008-3791-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
94 Gordon FD. Primary Sclerosing Cholangitis. Surgical Clinics of North America 2008;88:1385-407. [DOI: 10.1016/j.suc.2008.07.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
95 Aljiffry M, Abdulelah A, Walsh M, Peltekian K, Alwayn I, Molinari M. Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg. 2009;208:134-147. [PMID: 19228515 DOI: 10.1016/j.jamcollsurg.2008.09.007] [Cited by in Crossref: 148] [Cited by in F6Publishing: 137] [Article Influence: 10.6] [Reference Citation Analysis]
96 Alexopoulou A, Soultati A, Dourakis SP, Vasilieva L, Archimandritis AJ. Cholangiocarcinoma: A 7-year experience at a single center in Greece. World J Gastroenterol 2008; 14(40): 6213-6217 [PMID: 18985813 DOI: 10.3748/wjg.14.6213] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
97 Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008;48:308-21. [PMID: 18536057 DOI: 10.1002/hep.22310] [Cited by in Crossref: 492] [Cited by in F6Publishing: 463] [Article Influence: 35.1] [Reference Citation Analysis]
98 Wu Y, Johlin FC, Rayhill SC, Jensen CS, Xie J, Cohen MB, Mitros FA. Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma. Liver Transpl. 2008;14:279-286. [PMID: 18306329 DOI: 10.1002/lt.21287] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
99 Regimbeau J, Fuks D, Chatelain D, Riboulot M, Delcenserie R, Yzet T. Prise en charge chirurgicale du cholangiocarcinome hilaire résécable. Gastroentérologie Clinique et Biologique 2008;32:620-31. [DOI: 10.1016/j.gcb.2008.04.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
100 Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center’s experience. Am J Surg. 2008;196:160-169. [PMID: 18466862 DOI: 10.1016/j.amjsurg.2007.07.033] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
101 Aydin U, Yedibela S, Yazici P, Aydinli B, Zeytunlu M, Kilic M, Coker A. A new technique of biliary reconstruction after "high hilar resection" of hilar cholangiocarcinoma with tumor extension to secondary and tertiary biliary radicals. Ann Surg Oncol. 2008;15:1871-1879. [PMID: 18454297 DOI: 10.1245/s10434-008-9926-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
102 Heimbach JK. Successful liver transplantation for hilar cholangiocarcinoma: . Current Opinion in Gastroenterology 2008;24:384-8. [DOI: 10.1097/mog.0b013e3282f706ce] [Cited by in Crossref: 26] [Cited by in F6Publishing: 2] [Article Influence: 1.9] [Reference Citation Analysis]
103 Witzigmann H, Wiedmann M, Wittekind C, Mössner J, Hauss J. Therapeutical concepts and results for Klatskin tumors. Dtsch Arztebl Int 2008;105:156-61. [PMID: 19633782 DOI: 10.3238/arztebl.2008.0156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
104 Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Furuse J, Saito H, Tsuyuguchi T, Yamamoto M, Kayahara M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Hirano S, Amano H, Miura F; Japanese Association of Biliary Surgery; Japanese Society of Hepato-Biliary-Pancreatic Surgery; Japan Society of Clinical Oncology. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg. 2008;15:41-54. [PMID: 18274843 DOI: 10.1007/s00534-007-1279-5] [Cited by in Crossref: 137] [Cited by in F6Publishing: 126] [Article Influence: 9.8] [Reference Citation Analysis]
105 Blechacz BR, Gores GJ. Cholangiocarcinoma. Clinics in Liver Disease 2008;12:131-50. [DOI: 10.1016/j.cld.2007.11.003] [Cited by in Crossref: 156] [Cited by in F6Publishing: 147] [Article Influence: 11.1] [Reference Citation Analysis]
106 Mantel HT, Rosen CB, Heimbach JK, Nyberg SL, Ishitani MB, Andrews JC, McKusick MA, Haddock MG, Alberts SR, Gores GJ. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl. 2007;13:1372-1381. [PMID: 17427173 DOI: 10.1002/lt.21107] [Cited by in Crossref: 76] [Cited by in F6Publishing: 58] [Article Influence: 5.4] [Reference Citation Analysis]
107 Otani K, Chijiiwa K, Kai M, Ohuchida J, Nagano M, Tsuchiya K, Kondo K. Outcome of surgical treatment of hilar cholangiocarcinoma. J Gastrointest Surg. 2008;12:1033-1040. [PMID: 18085342 DOI: 10.1007/s11605-007-0453-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
108 Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR, Lodge JP. Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol. 2008;34:787-794. [PMID: 18036765 DOI: 10.1016/j.ejso.2007.10.005] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 5.5] [Reference Citation Analysis]
109 Lang H, Kaiser GM, Zöpf T, Sotiropoulos GC, Frilling A, Malagó M, Broelsch CE. [Surgical therapy of hilar cholangiocarcinoma]. Chirurg 2006;77:325-34. [PMID: 16568258 DOI: 10.1007/s00104-006-1177-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
110 Ristagno N, Knuth A, Pestalozzi BC. Is an aggressive surgical approach worthwhile in biliary cancer? Int Semin Surg Oncol 2007;4:26. [PMID: 17956626 DOI: 10.1186/1477-7800-4-26] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
111 Lafortune M, Denys A, Sauvanet A, Schmidt S. [Anatomy of the liver: what you need to know]. J Radiol. 2007;88:1020-1035. [PMID: 17762832 DOI: 10.1016/S0221-0363(07)89916-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
112 Masunari H, Shimada H, Endo I, Fujii Y, Tanaka K, Sekido H, Togo S. Surgical Anatomy of Hepatic Hilum with Special Reference of the Plate System and Extrahepatic Duct. J Gastrointest Surg 2008;12:1047-53. [DOI: 10.1007/s11605-007-0358-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
113 Sano T, Shimada K, Sakamoto Y, Esaki M, Kosuge T. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years. J Hepatobiliary Pancreat Surg. 2007;14:455-462. [PMID: 17909713 DOI: 10.1007/s00534-006-1194-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
114 Rossi M, Mennini G, Lai Q, Ginanni Corradini S, Drudi FM, Pugliese F, Berloco PB. Liver transplantation(). J Ultrasound 2007;10:28-45. [PMID: 23396075 DOI: 10.1016/j.jus.2007.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
115 Fevery J, Verslype C, Lai G, Aerts R, Van Steenbergen W. Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig Dis Sci. 2007;52:3123-3135. [PMID: 17431781 DOI: 10.1007/s10620-006-9681-4] [Cited by in Crossref: 99] [Cited by in F6Publishing: 80] [Article Influence: 6.6] [Reference Citation Analysis]
116 Xiao YH, Liu ZL, Guo AT, Wang Z, Peng SL. Potential malignancy and clinical management of solid pseudopapillary tumor of pancreas in children. Shijie Huaren Xiaohua Zazhi 2007; 15(9): 970-974 [DOI: 10.11569/wcjd.v15.i9.970] [Reference Citation Analysis]
117 Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 2007; 13(10): 1505-1515 [PMID: 17461441 DOI: 10.3748/wjg.v13.i10.1505] [Cited by in CrossRef: 88] [Cited by in F6Publishing: 76] [Article Influence: 5.9] [Reference Citation Analysis]
118 Shimoda M, Kubota K. Multi-disciplinary treatment for cholangiocellular carcinoma. World J Gastroenterol 2007; 13(10): 1500-1504 [PMID: 17461440 DOI: 10.3748/wjg.v13.i10.1500] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
119 Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Pedersen R, Kremers W, Nyberg SL, Ishitani MB, Rosen CB. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation. 2006;82:1703-1707. [PMID: 17198263 DOI: 10.1097/01.tp.0000253551.43583.d1] [Cited by in Crossref: 150] [Cited by in F6Publishing: 123] [Article Influence: 10.0] [Reference Citation Analysis]
120 He X, Zhang S, Zhu X, Wang D, Ma Y, Wang G, Ju W, Wu L, Huang J. Orthotopic liver transplantation with hepatopancreato-duodenectomy for hilar cholangiocarcinoma: . Chinese Medical Journal 2007;120:251-3. [DOI: 10.1097/00029330-200702010-00017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
121 Sun H, Zhuang P, Qin L, Ye Q, Wang L, Ren N, Zhang J, Qian Y, Lu L, Fan J, Tang Z. Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. J Surg Oncol 2007;96:37-45. [DOI: 10.1002/jso.20772] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
122 Cheng Q, Luo X, Zhang B, Jiang X, Yi B, Wu M. Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases. Ann Surg Oncol. 2007;14:1212-1219. [PMID: 17176983 DOI: 10.1245/s10434-006-9260-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
123 Pavey DA, Gress FG. The role of EUS-guided FNA for the evaluation of biliary strictures. Gastrointest Endosc. 2006;64:334-337. [PMID: 16923478 DOI: 10.1016/j.gie.2006.03.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
124 Slattery JM, Sahani DV. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist. 2006;11:913-922. [PMID: 16951395 DOI: 10.1634/theoncologist.11-8-913] [Cited by in Crossref: 68] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
125 Schmeding M, Neumann U, Neuhaus P. Colonic metastasis of Klatskin tumor: Case report and discussion of the current literature. World J Gastroenterol 2006; 12(33): 5393-5395 [PMID: 16981275 DOI: 10.3748/wjg.v12.i33.5393] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
126 Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 2006;244:230-239. [PMID: 16858185 DOI: 10.1097/01.sla.0000217639.10331.47] [Cited by in Crossref: 201] [Cited by in F6Publishing: 160] [Article Influence: 12.6] [Reference Citation Analysis]
127 LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH. Primary sclerosing cholangitis: summary of a workshop. Hepatology 2006;44:746-64. [PMID: 16941705 DOI: 10.1002/hep.21337] [Cited by in Crossref: 192] [Cited by in F6Publishing: 148] [Article Influence: 12.0] [Reference Citation Analysis]
128 Park JY, Park SW, Chung JB, Seong J, Kim KS, Lee WJ, Song SY. Concurrent Chemoradiotherapy With Doxifluridine and Paclitaxel for Extrahepatic Bile Duct Cancer. American Journal of Clinical Oncology 2006;29:240-5. [DOI: 10.1097/01.coc.0000217829.77404.22] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
129 Veroux M, Madia C, Fiamingo P, Caglià P, Valastro M, Amodeo C, Veroux P, Gagliano M, Basso S, D'Amico DF. Could a high resectability rate improve the long-term survival of patients with proximal bile duct cancer? J Surg Oncol 2006;93:199-205. [PMID: 16482599 DOI: 10.1002/jso.20256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
130 Dinant S, Gerhards MF, Rauws EAJ, Busch ORC, Gouma DJ, van Gulik TM. Improved Outcome of Resection of Hilar Cholangiocarcinoma (Klatskin Tumor). Ann Surg Oncol 2006;13:872-80. [DOI: 10.1245/aso.2006.05.053] [Cited by in Crossref: 139] [Cited by in F6Publishing: 58] [Article Influence: 8.7] [Reference Citation Analysis]
131 Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 2006;243:364-72. [PMID: 16495702 DOI: 10.1097/01.sla.0000201482.11876.14] [Cited by in Crossref: 363] [Cited by in F6Publishing: 314] [Article Influence: 22.7] [Reference Citation Analysis]
132 Fuchs M, Schepp W. Gibt es eine nichtchirurgische Therapie der Gallenwegskarzinome? Chirurg 2006;77:341-51. [DOI: 10.1007/s00104-006-1159-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
133 Kaiser GM, Mueller AB, Sauerwein W, Zhang HW, Westermann S, Frühauf NR, Kuehne CA, Stuschke M, Oldhafer KJ, Broelsch CE. Biliodigestive anastomosis after intraoperative irradiation in swine. J Invest Surg 2005;18:305-13. [PMID: 16319051 DOI: 10.1080/08941930500328748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
134 Wolfsen HC. Uses of photodynamic therapy in premalignant and malignant lesions of the gastrointestinal tract beyond the esophagus. J Clin Gastroenterol 2005;39:653-64. [PMID: 16082272 DOI: 10.1097/01.mcg.0000173930.60115.62] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
135 Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005;366:1303-1314. [PMID: 16214602 DOI: 10.1016/s0140-6736(05)67530-7] [Cited by in Crossref: 814] [Cited by in F6Publishing: 384] [Article Influence: 47.9] [Reference Citation Analysis]
136 Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, Gores GJ, Nagorney DM. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005;242:451-8; discussion 458-61. [PMID: 16135931 DOI: 10.1097/01.sla.0000179678.13285.fa] [Cited by in Crossref: 142] [Cited by in F6Publishing: 199] [Article Influence: 8.4] [Reference Citation Analysis]
137 Khandani AH, Wahl RL. Applications of PET in Liver Imaging. Radiologic Clinics of North America 2005;43:849-60. [DOI: 10.1016/j.rcl.2005.05.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
138 Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology. 2005;128:1655-1667. [PMID: 15887157 DOI: 10.1053/j.gastro.2005.03.040] [Cited by in Crossref: 326] [Cited by in F6Publishing: 307] [Article Influence: 19.2] [Reference Citation Analysis]
139 Yamada T, Arai T, Nagino M, Oda K, Shoda J, Suzuki H, Sugiyama Y, Nimura Y. Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer. Langenbecks Arch Surg 2005;390:421-9. [PMID: 15965653 DOI: 10.1007/s00423-005-0564-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
140 Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer. 2005;103:1210-1216. [PMID: 15685618 DOI: 10.1002/cncr.20906] [Cited by in Crossref: 166] [Cited by in F6Publishing: 150] [Article Influence: 9.8] [Reference Citation Analysis]
141 Kanazawa H, Nagino M, Kamiya S, Komatsu S, Mayumi T, Takagi K, Asahara T, Nomoto K, Tanaka R, Nimura Y. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 2005;390:104-13. [PMID: 15711820 DOI: 10.1007/s00423-004-0536-1] [Cited by in Crossref: 162] [Cited by in F6Publishing: 128] [Article Influence: 9.5] [Reference Citation Analysis]
142 Kraus T, Klenke F, Schemmer P, Büchler M. Chirurgische Strategie beim Karzinom der Gallenblase und der extrahepatischen Gallenwege. Visc Med 2004;20:272-8. [DOI: 10.1159/000083012] [Reference Citation Analysis]
143 Wiedmann M, Schoppmeyer K, Mössner J, Caca K. Palliative Therapie des Gallengangkarzinoms. Visc Med 2004;20:286-92. [DOI: 10.1159/000083018] [Reference Citation Analysis]
144 Anderson CD, Pinson CW, Berlin J, Chari RS. Diagnosis and treatment of cholangiocarcinoma. Oncologist 2004;9:43-57. [PMID: 14755014 DOI: 10.1634/theoncologist.9-1-43] [Cited by in Crossref: 216] [Cited by in F6Publishing: 202] [Article Influence: 12.0] [Reference Citation Analysis]
145 Sotiropoulos GC, Lang H, Niebel W, Malagó M, Broelsch CE. 10-YEAR TUMOR-FREE SURVIVAL AFTER INTRAOPERATIVE RADIATION THERAPY AND SECONDARY LIVER TRANSPLANTATION FOR HILAR CHOLANGIOCARCINOMA. Transplantation 2004;77:1625. [DOI: 10.1097/01.tp.0000116391.25570.94] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
146 Kamiya S, Nagino M, Kanazawa H, Komatsu S, Mayumi T, Takagi K, Asahara T, Nomoto K, Tanaka R, Nimura Y. The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora. Ann Surg 2004;239:510-7. [PMID: 15024312 DOI: 10.1097/01.sla.0000118594.23874.89] [Cited by in Crossref: 144] [Cited by in F6Publishing: 119] [Article Influence: 8.0] [Reference Citation Analysis]
147 Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey J. Total and segmental liver volume variations: Implications for liver surgery. Surgery 2004;135:404-10. [DOI: 10.1016/j.surg.2003.08.024] [Cited by in Crossref: 174] [Cited by in F6Publishing: 136] [Article Influence: 9.7] [Reference Citation Analysis]
148 Nissen NN, Cavazzoni E, Tran TT, Poordad FP. Emerging Role of Transplantation for Primary Liver Cancers: . The Cancer Journal 2004;10:88-96. [DOI: 10.1097/00130404-200403000-00004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
149 Fritscher-Ravens A, Broering DC, Knoefel WT, Rogiers X, Swain P, Thonke F, Bobrowski C, Topalidis T, Soehendra N. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol. 2004;99:45-51. [PMID: 14687140 DOI: 10.1046/j.1572-0241.2003.04006.x] [Cited by in Crossref: 176] [Cited by in F6Publishing: 183] [Article Influence: 9.8] [Reference Citation Analysis]
150 Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, Makuuchi M. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73-83. [PMID: 12832968 DOI: 10.1097/00000658-200307000-00010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
151 Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84-92. [PMID: 12832969 DOI: 10.1097/00000658-200307000-00011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
152 Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84-92. [PMID: 12832969 DOI: 10.1097/01.sla.0000074984.83031.02] [Cited by in Crossref: 143] [Cited by in F6Publishing: 99] [Article Influence: 7.5] [Reference Citation Analysis]
153 Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, Makuuchi M. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73-83. [PMID: 12832968 DOI: 10.1097/01.sla.0000074960.55004.72.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, Makuuchi M. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73-83. [PMID: 12832968 DOI: 10.1097/01.sla.0000074960.55004.72] [Cited by in Crossref: 164] [Cited by in F6Publishing: 112] [Article Influence: 8.6] [Reference Citation Analysis]
155 Kondo S, Katoh H, Hirano S, Ambo Y, Tanaka E, Okushiba S. Portal vein resection and reconstruction prior to hepatic dissection during right hepatectomy and caudate lobectomy for hepatobiliary cancer. Br J Surg. 2003;90:694-697. [PMID: 12808616 DOI: 10.1002/bjs.4084] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
156 Puhalla H, Gruenberger T, Pokorny H, Soliman T, Wrba F, Sponer U, Winkler T, Ploner M, Raderer M, Steininger R. Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis. World J Surg. 2003;27:680-684. [PMID: 12733000 DOI: 10.1007/s00268-003-6656-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
157 Sudan D, DeRoover A, Chinnakotla S, Fox I, Shaw B Jr, McCashland T, Sorrell M, Tempero M, Langnas A. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant. 2002;2:774-779. [PMID: 12243499 DOI: 10.1034/j.1600-6143.2002.20812.x] [Cited by in Crossref: 220] [Cited by in F6Publishing: 177] [Article Influence: 11.6] [Reference Citation Analysis]
158 Hassoun Z, Gores GJ, Rosen CB. Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma. Surg Oncol Clin N Am. 2002;11:909-921. [PMID: 12607579 DOI: 10.1016/s1055-3207(02)00036-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
159 Tojima Y, Nagino M, Ebata T, Uesaka K, Kamiya J, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg. 2003;237:201-207. [PMID: 12560778 DOI: 10.1097/01.sla.0000048446.18118.fc] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
160 Ebata T, Watanabe H, Ajioka Y, Oda K, Nimura Y. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg. 2002;89:1260-1267. [PMID: 12296893 DOI: 10.1046/j.1365-2168.2002.02211.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 77] [Article Influence: 4.7] [Reference Citation Analysis]
161 Kaiser GM, Oldhafer K, Zhang H, Frühauf N, Müller A, Sauerwein W, Stuschke M, Broelsch C. Treatment of nonresectable proximal bile duct carcinoma using intraoperative radiotherapy combined with hepatojejunostomy: Non-Resectable Bile Duct Carcinoma. J Surg Oncol 2002;81:55-7. [DOI: 10.1002/jso.10130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
162 Ringe B. Transplantation for liver tumors: current status: Transplantation for liver tumors. Liver 2002;22:1-7. [DOI: 10.1034/j.1600-0676.2002.220101.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
163 Fritscher-Ravens A, Bohuslavizki KH, Broering DC, Jenicke L, Schäfer H, Buchert R, Rogiers X, Clausen M. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 2001;22:1277-85. [PMID: 11711897 DOI: 10.1097/00006231-200112000-00002] [Cited by in Crossref: 112] [Cited by in F6Publishing: 88] [Article Influence: 5.6] [Reference Citation Analysis]
164 Shimoda M, Farmer DG, Colquhoun SD, Rosove M, Ghobrial RM, Yersiz H, Chen P, Busuttil RW. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl. 2001;7:1023-1033. [PMID: 11753904 DOI: 10.1053/jlts.2001.29419] [Cited by in Crossref: 165] [Cited by in F6Publishing: 127] [Article Influence: 8.3] [Reference Citation Analysis]
165 Bouras N, Caudry M, Saric J, Bonnel C, Rullier E, Trouette R, Demeaux H, Maire J. Radiothérapie conformationnelle des cholangiocarcinomes de la voie biliaire principale localement évolués. Cancer/Radiothérapie 2002;6:22-9. [DOI: 10.1016/s1278-3218(01)00144-5] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
166 Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, Youssef BA M, Klimstra D, Blumgart LH. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-17; discussion 517-9. [PMID: 11573044 DOI: 10.1097/00000658-200110000-00010] [Cited by in Crossref: 887] [Cited by in F6Publishing: 813] [Article Influence: 42.2] [Reference Citation Analysis]
167 Johnson SR, Kelly BS, Pennington LJ, Hanto DW. A single center experience with extrahepatic cholangiocarcinomas. Surgery 2001;130:584-90; discussion 590-2. [PMID: 11602888 DOI: 10.1067/msy.2001.117104] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
168 Vellar ID. Preliminary study of the anatomy of the venous drainage of the intrahepatic and extrahepatic bile ducts and its relevance to the practice of hepatobiliary surgery. ANZ J Surg. 2001;71:418-422. [PMID: 11450918 DOI: 10.1046/j.1440-1622.2001.02150.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
169 Pisters PW, Hudec WA, Hess KR, Lee JE, Vauthey JN, Lahoti S, Raijman I, Evans DB. Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 2001;234:47-55. [PMID: 11420482 DOI: 10.1097/00000658-200107000-00008] [Cited by in Crossref: 220] [Cited by in F6Publishing: 198] [Article Influence: 10.5] [Reference Citation Analysis]
170 Kyokane T, Nagino M, Oda K, Nimura Y. An experimental study of selective intrahepatic biliary ablation with ethanol. J Surg Res. 2001;96:188-196. [PMID: 11266272 DOI: 10.1006/jsre.2001.6081] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
171 Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233:385-392. [PMID: 11224627 DOI: 10.1097/00000658-200103000-00013] [Cited by in Crossref: 222] [Cited by in F6Publishing: 194] [Article Influence: 10.6] [Reference Citation Analysis]
172 Blanchet MC, Ducerf C, Benoit L, Gérard JP, Baulieux J. [Proximal bile duct cholangiocarcinomas]. Ann Chir. 2000;125:825-831. [PMID: 11244588 DOI: 10.1016/S0003-3944(00)00015-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
173 Nagino M, Kanai M, Morioka A, Yamamoto H, Kawabata Y, Hayakawa N, Nimura Y. Portal and arterial embolization before extensive liver resection in patients with markedly poor functional reserve. J Vasc Interv Radiol 2000;11:1063-8. [PMID: 10997472 DOI: 10.1016/s1051-0443(07)61340-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
174 Figueras J, Llado L, Valls C, Serrano T, Ramos E, Fabregat J, Rafecas A, Torras J, Jaurrieta E. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl. 2000;6:786-794. [PMID: 11084070 DOI: 10.1053/jlts.2000.18507] [Cited by in Crossref: 71] [Cited by in F6Publishing: 78] [Article Influence: 3.2] [Reference Citation Analysis]
175 Tsao JI, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, Miyachi M, Kanai M, Uesaka K, Oda K. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg. 2000;232:166-174. [PMID: 10903592 DOI: 10.1097/00000658-200008000-00003] [Cited by in Crossref: 182] [Cited by in F6Publishing: 156] [Article Influence: 8.3] [Reference Citation Analysis]
176 Gerhards M, Gonzalez Gonzalez D, ten Hoopen-neumann H, van Gulik T, de Wit TT, Gouma D. Prevention of implantation metastases after resection of proximal bile duct tumours with pre-operative low dose radiation therapy. European Journal of Surgical Oncology (EJSO) 2000;26:480-5. [DOI: 10.1053/ejso.1999.0926] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.3] [Reference Citation Analysis]
177 Chamberlain RS, Blumgart LH. Hilar cholangio-carcinoma: a review and commentary. Ann Surg Oncol. 2000;7:55-66. [PMID: 10674450 DOI: 10.1007/s10434-000-0055-4] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 4.3] [Reference Citation Analysis]
178 Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, Wex C, Lobeck H, Hintze R. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230:808-18; discussion 819. [PMID: 10615936 DOI: 10.1097/00000658-199912000-00010] [Cited by in Crossref: 490] [Cited by in F6Publishing: 399] [Article Influence: 22.3] [Reference Citation Analysis]
179 Bismuth H, Majno PE. Hepatobiliary surgery. Journal of Hepatology 2000;32:208-24. [DOI: 10.1016/s0168-8278(00)80427-4] [Cited by in Crossref: 69] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
180 Parks R, Currie E, Madhavan K, Garden O. Increased bacterobilia associated with preoperative biliary drainage in patients with hilar cholangiocarcinoma. HPB 2000;2:375-81. [DOI: 10.1016/s1365-182x(17)30774-8] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
181 Strong RW. Transplantation for liver and biliary cancer. Semin Surg Oncol 2000;19:189-99. [DOI: 10.1002/1098-2388(200009)19:2<189::aid-ssu10>3.0.co;2-u] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
182 Yokoyama Y, Hiyama E, Murakami Y, Matsuura Y, Yokoyama T. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma. Cancer 1999;86:1691-9. [DOI: 10.1002/(sici)1097-0142(19991101)86:9<1691::aid-cncr10>3.0.co;2-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
183 Saiura A, Takayama T, Sano K, Toyoda H, Abe H, Kubota K, Mori M, Makuuchi M. Metachronous bile duct cancer in a patient surviving for a decade and undergoing curative surgery twice. Jpn J Clin Oncol. 1999;29:353-355. [PMID: 10470661 DOI: 10.1093/jjco/29.7.353] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
184 Launois B, Terblanche J, Lakehal M, Catheline JM, Bardaxoglou E, Landen S, Campion JP, Sutherland F, Meunier B. Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg 1999;230:266-75. [PMID: 10450742 DOI: 10.1097/00000658-199908000-00018] [Cited by in Crossref: 113] [Cited by in F6Publishing: 98] [Article Influence: 4.9] [Reference Citation Analysis]
185 Garg PK, Tandon R. Preoperative assessment of cholangiocarcinoma: Meeting the challenge. Journal of Gastroenterology and Hepatology 1999;14:615-7. [DOI: 10.1046/j.1440-1746.1999.01927.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
186 Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH. Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998;228:385-94. [PMID: 9742921 DOI: 10.1097/00000658-199809000-00011] [Cited by in Crossref: 325] [Cited by in F6Publishing: 265] [Article Influence: 13.5] [Reference Citation Analysis]
187 Iwatsuki S, Todo S, Marsh J, Madariaga JR, Lee RG, Dvorchik I, Fung JJ, Starzl TE. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. Journal of the American College of Surgeons 1998;187:358-64. [DOI: 10.1016/s1072-7515(98)00207-5] [Cited by in Crossref: 176] [Cited by in F6Publishing: 55] [Article Influence: 7.3] [Reference Citation Analysis]
188 Jonas S, Bechstein WO, Keck H, Veltzke W, Hintze R, Vogl T, Neuhaus P. Partial or total resection of the biliary tract — Surgical strategies for hilar cholangiocarcinoma. Acta Chir Austriaca 1998;30:211-4. [DOI: 10.1007/bf02620207] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
189 Jonas S, Kling N, Guckelberger O, Keck H, Bechstein WO, Neuhaus P. Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma First long-terms results. Transplant Int 1998;11:S206-8. [DOI: 10.1111/j.1432-2277.1998.tb01116.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
190 Pichlmayr R, Weimann A, Oldhafer KJ, Schlitt HJ, Tusch G, Raab R. Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinoma. Eur J Surg Oncol. 1998;24:60-67. [PMID: 9542520 DOI: 10.1016/s0748-7983(98)80130-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
191 Mcmasters KM, Tuttle TM, Leach SD, Rich T, Cleary KR, Evans DB, Curley SA. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. The American Journal of Surgery 1997;174:605-9. [DOI: 10.1016/s0002-9610(97)00203-1] [Cited by in Crossref: 139] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
192 Kapoor VK, Benjamin IS. Biliary malignancies. Baillière's Clinical Gastroenterology 1997;11:801-36. [DOI: 10.1016/s0950-3528(97)90022-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
193 Lee RG, Emond J. Prognostic Factors and Management of Carcinomas of the Gallbladder and Extrahepatic Bile Ducts. Surgical Oncology Clinics of North America 1997;6:639-59. [DOI: 10.1016/s1055-3207(18)30320-x] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
194 Pichlmayr R, Weimann A, Tusch G, Schlitt HJ. Indications and Role of Liver Transplantation for Malignant Tumors. The Oncologist 1997;2:164-70. [DOI: 10.1634/theoncologist.2-3-164] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]